Scientists have reported encouraging early tests of a gene therapy strategy against Angelman syndrome, a neurodevelopmental disorder that features poor muscle control and balance, hard-to-treat epilepsy, and intellectual disabilities.
from Latest Science News -- ScienceDaily https://ift.tt/3En93CT
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment